AAPL 184.35 1.1134% MSFT 411.6876 2.364% GOOG 145.3444 1.0459% GOOGL 144.175 1.14% AMZN 174.33 3.4047% NVDA 784.65 16.2927% META 486.18 3.878% TSLA 197.565 1.435% TSM 129.25 3.1195% LLY 769.655 3.1834% V 283.785 2.5383% AVGO 1304.8 6.3017% JPM 183.325 1.3405% UNH 525.425 0.6619% NVO 124.57 3.01% WMT 175.35 0.9499% LVMUY 182.36 1.7066% XOM 104.775 -0.0715% LVMHF 909.7617 1.9427% MA 471.85 2.7884%

Rite Aid Corporation

Healthcare US RAD


Last update at 2024-01-23T20:02:01.870719Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Income before tax -756.40300M -542.25800M -120.22700M -81.61200M -589.47700M
Minority interest - - - - -
Net income -749.93600M -538.47800M -100.07000M -469.21900M -422.21300M
Selling general administrative 4902.09M 4998.76M 4657.19M 4587.34M 4592.38M
Selling and marketing expenses - - - - -
Gross profit 4803.94M 5106.49M 4704.32M 4726.76M 4676.35M
Reconciled depreciation 276.58M 295.69M 327.12M 328.28M 357.88M
Ebit -98.14700M 72.62M 47.14M 139.42M 83.98M
Ebitda 178.44M 368.31M 374.26M 467.70M 441.86M
Depreciation and amortization 276.58M 295.69M 327.12M 328.28M 357.88M
Non operating income net other 148.73M -8.74000M 117.00M 55.69M -0.55400M
Operating income -98.14700M 72.62M 47.14M 139.42M 83.98M
Other operating expenses 24190.05M 24495.64M 23996.10M 21788.97M 21555.58M
Interest expense 224.40M 191.60M 201.39M 229.66M 227.73M
Tax provision -6.46700M -3.78000M -20.15700M 387.61M 77.48M
Interest income 224.40M 191.60M 201.39M 229.66M 227.73M
Net interest income -224.39900M -191.60100M -201.38800M -229.65700M -227.72800M
Extraordinary items 0.00000M 0.00000M 9.16M 17.05M 244.74M
Non recurring 371.20M 229.00M 29.85M - -107.99400M
Other items - - - - -
Income tax expense -6.46700M -3.78000M -20.15700M 387.61M 77.48M
Total revenue 24091.90M 24568.26M 24043.24M 21928.39M 21639.56M
Total operating expenses 4902.09M 5033.88M 4657.19M 4587.34M 4592.38M
Cost of revenue 19287.96M 19461.76M 19338.92M 17201.63M 16963.21M
Total other income expense net -658.25600M -614.87700M -167.36400M -221.03400M -445.72600M
Discontinued operations - - 9.16M 17.05M 244.74M
Net income from continuing ops -749.93600M -538.47800M -100.07000M -469.21900M -666.95400M
Net income applicable to common shares -749.93600M -538.47800M -90.90900M -452.17400M -422.21300M
Preferred stock and other adjustments - - - - -
Breakdown 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Total assets 7527.36M 8529.00M 9335.40M 9452.37M 7591.37M
Intangible assets 250.11M 291.20M 340.52M 359.49M 448.71M
Earning assets - - - - -
Other current assets 93.19M 106.75M 106.94M 181.79M 179.13M
Total liab 8169.14M 8429.97M 8720.25M 8777.84M 6404.68M
Total stockholder equity -641.77600M 99.03M 615.15M 674.53M 1186.69M
Deferred long term liab - - - - -
Other current liab 724.53M 780.63M 642.36M 37.06M 727.73M
Common stock 56.63M 55.75M 55.14M 54.72M 1080.32M
Capital stock 56.63M 55.75M 55.14M 54.72M 54.02M
Retained earnings -6601.51700M -5851.58100M -5313.10300M -5222.19400M -4713.24400M
Other liab - 151.98M 208.21M 204.44M 482.89M
Good will 507.94M 879.14M 1108.14M 1108.14M 1108.14M
Other assets 63.29M 106.61M 139.96M 157.99M 624.29M
Cash 157.15M 39.72M 160.90M 218.18M 144.35M
Cash and equivalents 157.15M 39.72M 160.90M 218.18M 144.35M
Total current liabilities 2727.88M 2933.09M 2602.95M 2766.46M 2443.14M
Current deferred revenue - - - 746.32M 80.71M
Net debt 5662.36M 5886.38M 6271.35M 6087.76M 3350.41M
Short term debt 508.74M 581.20M 523.16M 499.00M 16.11M
Short long term debt 6.33M 5.54M 6.41M 8.84M 16.11M
Short long term debt total 5819.52M 5926.10M 6432.25M 6305.94M 3494.76M
Other stockholder equity 5917.96M 5910.30M 5897.17M 5890.90M 4850.67M
Property plant equipment 3404.98M 3802.70M 4144.58M 1215.84M 1308.51M
Total current assets 3301.05M 3449.36M 3595.17M 3700.64M 4101.72M
Long term investments - - - - -
Net tangible assets -1399.82400M -1071.29900M -833.50100M -793.10000M -370.15200M
Short term investments - - - - 7.19M
Net receivables 1149.96M 1343.50M 1462.44M 1286.79M 1788.71M
Long term debt 2925.26M 2732.99M 3063.09M 3077.27M 3454.59M
Inventory 1900.74M 1959.39M 1864.89M 1921.60M 1871.94M
Accounts payable 1494.61M 1571.26M 1437.42M 1484.08M 1618.59M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -14.85200M -15.43700M -24.05400M -48.89800M -31.05900M
Additional paid in capital - - - - -
Common stock total equity 56.63M 55.75M 55.14M 54.72M 54.02M
Preferred stock total equity - - - - -
Retained earnings total equity -6601.51700M -5851.58100M -5313.10300M -5222.19400M -4713.24400M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 50.92M 86.54M 132.03M 148.33M 215.21M
Deferred long term asset charges - - - - 409.08M
Non current assets total 4226.31M 5079.65M 5740.23M 5751.73M 3489.65M
Capital lease obligations 2887.93M 3187.57M 3362.76M 3219.83M 24.06M
Long term debt total 2937.84M 2747.82M 3063.09M 3077.27M 3478.65M
Breakdown 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Investments -104.75900M -134.07300M -15.02500M -86.54200M 2.59M
Change to liabilities -207.59100M 207.79M -35.37200M -154.23000M -313.98100M
Total cashflows from investing activities -104.75900M -134.07300M -15.02500M -149.84900M -198.55200M
Net borrowings 277.29M -363.79200M -8.61900M 600.00M 803.41M
Total cash from financing activities 274.63M -366.38000M -65.24300M -326.65200M -540.50400M
Change to operating activities - 72.92M 1.98M -86.40700M -438.90600M
Net income -749.93600M -538.47800M -100.07000M -469.21900M -666.95400M
Change in cash 117.43M -121.18100M -57.27800M 73.83M -302.98100M
Begin period cash flow 39.72M 160.90M 218.18M 144.35M 447.33M
End period cash flow 157.15M 39.72M 160.90M 218.18M 144.35M
Total cash from operating activities -52.43900M 379.27M 22.99M 487.02M -228.66500M
Issuance of capital stock 0.00000M 0.00000M 0.05M 0.00000M 2.29M
Depreciation 276.58M 295.69M 327.12M 328.28M 357.88M
Other cashflows from investing activities 110.53M 86.64M 284.70M 63.31M 660.38M
Dividends paid - - - - -
Change to inventory 5.16M -97.11200M 177.26M 15.14M -44.64500M
Change to account receivables 151.61M 54.09M -182.40400M 486.56M -75.84400M
Sale purchase of stock 0.00000M 0.00000M 0.05M - 2.29M
Other cashflows from financing activities 552.57M 319.66M 993.24M 604.45M -102.42800M
Change to netincome 294.74M 245.40M -174.69600M 261.88M 513.88M
Capital expenditures 247.69M 220.71M 224.94M 214.39M 244.69M
Change receivables 151.61M 54.09M -182.40400M 486.56M -75.84400M
Cash flows other operating -572.93900M -326.56900M 5.99M -450.61500M -665.95400M
Exchange rate changes - - - - -
Cash and cash equivalents changes 117.43M -121.18100M -69.39900M 34.36M -302.98100M
Change in working capital -100.47800M 169.12M -38.52900M 323.24M -433.47000M
Stock based compensation 11.54M 13.05M 13.00M 16.09M 12.12M
Other non cash items 502.15M 446.60M -167.90500M -97.26300M 406.12M
Free cash flow -300.12400M 158.56M -201.95100M 272.63M -473.35400M


  • Previous Close -
  • Market Cap36.76M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield0.0%
  • EBITDA282.87M
  • Revenue TTM23730.48M
  • Revenue Per Share TTM432.35
  • Gross Profit TTM 4803.94M
  • Diluted EPS TTM-14.34

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Rite Aid Corporation
- -% - 0.0 0.0 0.0099 3.77 0.27 -17.1507
Walgreens Boots Alliance Inc
-0.175 0.80% 21.57 0.0 7.60 0.16 1.09 0.39 -21.1795
Raia Drogasil SA ADR
-0.003 0.05% 5.53 47.15 32.68 0.34 9.83 0.35 3.29
Alibaba Health Information Technology Limited
0.0 0.0% 8.86 63.53 135.14 0.27 3.41 0.19 5.91
Alibaba Health Information Technology Limited
0.01 3.39% 0.45 48.00 62.11 0.25 3.04 0.20 6.01

Reports Covered

Stock Research & News


Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

Rite Aid Corporation

1200 Intrepid Avenue, Philadelphia, PA, United States

Key Executives

Name Title Year Born
Ms. Heyward Rutledge Donigan B.A. Pres, CEO & Director 1961
Mr. Matthew C. Schroeder CFO & Exec. VP 1970
Mr. Paul D. Gilbert Exec. VP, Gen. Counsel & Corp. Sec. 1967
Mr. Brian T. Hoover Chief Accounting Officer & Sr. VP 1965
Mr. Justin L. Mennen Exec. VP and Chief Technology & Digital Officer 1981
Byron Purcell VP of Investor Relations & Treasurer NA
Joy Errico Seusing Sr. VP & Chief Communications Officer NA
Mr. Frank G. Vitrano Chief Strategic Bus. Devel. Officer 1955
Ms. Jessica Kazmaier Exec. VP & Chief HR Officer 1978
Mr. Christopher S. Hall Sr. VP of Pharmacy Services 1965

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).